Avanir, a biotechnology company, thinks it might have developed an improved formulation of a widely used migraine drug. Read more about this development in November's News to Know.
“Your article on Cluster Headaches is the most accurate so far. I can now show my coworkers what I go through. The fact is that I manage mine very well, utilizing all the methods you mention.”